Cargando…
Can p63 serve as a biomarker for diagnosing giant cell tumor of bone? A systematic review and meta-analysis
BACKGROUND: Tumor protein p63 (p63) has been reported to be highly expressed in giant cell tumor of bone (GCTB). Whether p63 can be treated as a diagnostic marker for GCTB remains unclear. OBJECTIVE: We conducted a meta-analysis to evaluate the applicability of p63 in diagnosing GCTB. DESIGN AND SET...
Autores principales: | Wan, Zihao, Lee, Chien-Wei, Yuan, Shuai, Lee, Oscar Kuang-Shen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Paulista de Medicina - APM
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673867/ https://www.ncbi.nlm.nih.gov/pubmed/33111920 http://dx.doi.org/10.1590/1516-3180.2020.0021.R3.24062020 |
Ejemplares similares
-
Can p63 serve as a biomarker for giant cell tumor of bone? A Moroccan experience
por: Hammas, Nawal, et al.
Publicado: (2012) -
p63 as a prognostic marker for giant cell tumor of bone
por: Yanagisawa, Michiro, et al.
Publicado: (2013) -
Measurement of IgG Levels Can Serve as a Biomarker in Newly Diagnosed Diabetic Children
por: Haroun, Medhat, et al.
Publicado: (2007) -
Galectins can serve as biomarkers in COVID-19: A comprehensive systematic review and meta-analysis
por: Behnoush, Amir Hossein, et al.
Publicado: (2023) -
Can the vagus nerve serve as biomarker for vata dosha activity?
por: Sumantran, Venil N., et al.
Publicado: (2019)